All News

AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.

Insulin aspart injection (Fiasp, Novo Nordisk) has been approved for use as a new mealtime insulin option for children with diabetes.

The critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain

The New Drug Application is seeking approval for ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV in adults.

Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.

A new study examined diabetes as an independent predictor of heart failure. 

A 2016 California policy that eliminated non-medical vaccination exemptions for schoolchildren was linked to an increase in vaccine coverage.

Pharmacies can play an important role in raising awareness about efficient medication disposal methods.

Olaparib (Lynparza, Merck and AstraZeneca) is approved for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic cancer.

In 2020, we know there will be a renewed focus on collaborating across health care specialties while reducing costs.

The approvals were granted to generic apixaban applications from Micro Labs Limited and Mylan Pharmaceuticals Inc.

Our most-read FDA approval articles from 2019. 

Walgreens, CVS Health, and Rite Aid are supporting the recently-launched “Ready, Set, PrEP” program.

Albertsons is expanding its partnership with Genomind to offer patients genetic testing to guide mental health medication management.

Many in community pharmacy worry that there are too many pharmacists for not enough jobs-whether it’s true or not is up for debate.

Simon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.

Ongoing threats to the safety of intravenous (IV) drug delivery include drug shortages and lack of IV product standardization, according to an expert panel.

Initiating conversation takes time and effort.

Invasive methods did not perform better than drug treatment in patients with stable ischemic heart disease

Ubrogepant (Ubrelvy) is the first oral calcitonin gene-related peptide receptor antagonist approved by the FDA for the acute treatment of migraine.

A new study of a vaccine used against a pneumonia-causing bacteria found that cases of severe pneumonia decreased by 35% among those children who had received the vaccine.

Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo and AstraZeneca) is a new treatment option for patients with HER2-positive breast cancer who have progressed after 2 or more prior regimens.

Practical tips to help keep patients safe.

The proposed rule would allow for the importation of certain drugs from Canada.

As 2019 draws to a close, let’s look back at some of the top pharmacy news stories of the year.

Pharmacists can play an integral role in transitions-of-care for patients with chronic obstructive pulmonary disease (COPD) to prevent hospital readmissions.

Osteoarthritis is the most common type of arthritis, affecting nearly 54 million people.

Technology has long pushed the limits of the possible in pharmacy.